Patten Group, Inc. Sanofi Transaction History

Patten Group, Inc.

$460 Million
Q2 2025

A detailed history of Patten Group, Inc. transactions in Sanofi stock. As of the latest transaction made, Patten Group, Inc. holds 11,697 shares of SNY stock, worth $585,083. This represents 0.12% of its overall portfolio holdings.

Number of Shares

11,697

Previous 11,670 0.23%

Holding current value

$585,083

Previous $647,000 12.67%

% of portfolio

0.12%

Previous 0.15%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	BUY	$47.62 - $55.44 $1,285 - $1,496	27 Added 0.23%	11,697 $565,000
Q1 2025 May 14, 2025	SELL	$48.15 - $59.42 $24,893 - $30,720	-517 Reduced 4.24%	11,670 $647,000
Q4 2024 Feb 06, 2025	SELL	$45.89 - $57.31 $215,315 - $268,898	-4,692 Reduced 27.8%	12,187 $587,000
Q3 2024 Oct 08, 2024	SELL	$48.54 - $58.53 $31,745 - $38,278	-654 Reduced 3.73%	16,879 $973,000
Q2 2024 Jul 25, 2024	SELL	$45.39 - $50.36 $96,045 - $106,561	-2,116 Reduced 10.77%	17,533 $850,000
Q1 2024 Apr 17, 2024	BUY	$45.75 - $52.48 $12,535 - $14,379	274 Added 1.41%	19,649 $954,000
Q4 2023 Jan 10, 2024	BUY	$43.13 - $54.79 $154,276 - $195,983	3,577 Added 22.64%	19,375 $963,000
Q3 2023 Oct 12, 2023	BUY	$50.95 - $55.2 $1,834 - $1,987	36 Added 0.23%	15,798 $847,000
Q2 2023 Jul 26, 2023	SELL	$50.45 - $57.18 $7,315 - $8,291	-145 Reduced 0.91%	15,762 $849,000
Q1 2023 Apr 06, 2023	SELL	$45.86 - $54.45 $2,293 - $2,722	-50 Reduced 0.31%	15,907 $865,000
Q4 2022 Feb 10, 2023	SELL	$38.86 - $48.55 $23,005 - $28,741	-592 Reduced 3.58%	15,957 $772,000
Q3 2022 Oct 13, 2022	SELL	$37.22 - $100.5 $28,026 - $75,676	-753 Reduced 4.35%	16,549 $643,000
Q2 2022 Jul 18, 2022	BUY	$48.99 - $57.46 $9,602 - $11,262	196 Added 1.15%	17,302 $869,000
Q1 2022 Apr 28, 2022	SELL	$48.48 - $53.65 $20,991 - $23,230	-433 Reduced 2.47%	17,106 $878,000
Q4 2021 Jan 20, 2022	SELL	$47.07 - $52.35 $23,676 - $26,332	-503 Reduced 2.79%	17,539 $879,000
Q3 2021 Nov 15, 2021	BUY	$47.89 - $53.12 $78,395 - $86,957	1,637 Added 9.98%	18,042 $870,000
Q2 2021 Aug 03, 2021	BUY	$49.36 - $54.25 $41,857 - $46,004	848 Added 5.45%	16,405 $864,000
Q1 2021 Apr 23, 2021	BUY	$45.46 - $50.51 $204,660 - $227,396	4,502 Added 40.72%	15,557 $769,000
Q4 2020 Feb 02, 2021	BUY	$45.3 - $51.62 $45,481 - $51,826	1,004 Added 9.99%	11,055 $537,000
Q3 2020 Oct 19, 2020	BUY	$49.47 - $53.77 $81,229 - $88,290	1,642 Added 19.53%	10,051 $504,000
Q2 2020 Jul 20, 2020	BUY	$42.91 - $52.5 $28,878 - $35,332	673 Added 8.7%	8,409 $429,000
Q1 2020 Apr 16, 2020	BUY	$38.02 - $51.66 $16,310 - $22,162	429 Added 5.87%	7,736 $338,000
Q4 2019 Jan 14, 2020	BUY	$44.25 - $50.86 $3,363 - $3,865	76 Added 1.05%	7,307 $367,000
Q3 2019 Oct 22, 2019	BUY	$40.34 - $46.64 $2,097 - $2,425	52 Added 0.72%	7,231 $335,000
Q2 2019 Jul 11, 2019	BUY	$40.43 - $44.3 $9,703 - $10,632	240 Added 3.46%	7,179 $311,000
Q1 2019 May 14, 2019	SELL	$40.83 - $45.43 $5,634 - $6,269	-138 Reduced 1.95%	6,939 $307,000
Q4 2018 Feb 12, 2019	SELL	$41.48 - $45.59 $20,740 - $22,795	-500 Reduced 6.6%	7,077 $307,000
Q3 2018 Nov 14, 2018	BUY	$40.0 - $44.84 $1,320 - $1,479	33 Added 0.44%	7,577 $338,000
Q2 2018 Aug 14, 2018	SELL	$37.63 - $41.22 $5,080 - $5,564	-135 Reduced 1.76%	7,544 $302,000
Q1 2018 May 11, 2018	SELL	$38.98 - $45.76 $9,745 - $11,440	-250 Reduced 3.15%	7,679 $308,000
Q4 2017 Feb 02, 2018	SELL	$42.86 - $50.61 $4,286 - $5,061	-100 Reduced 1.25%	7,929 $341,000
Q3 2017 Dec 13, 2017	SELL	$47.04 - $50.34 $20,603 - $22,048	-438 Reduced 5.17%	8,029 $400,000
Q3 2017 Nov 14, 2017	BUY	$47.04 - $50.34 $19,474 - $20,840	414 Added 5.14%	8,467 $400,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,053	8,053 $387,000

Others Institutions Holding SNY

# of Institutions

825

Shares Held

260M

Call Options Held

1.75M

Put Options Held

1.6M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $125B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patten Group, Inc. with notifications on news.

Account